ǰÑÔ
Àà·çʪÐÔÊàŦÑ×(rheumatoid arthritis,RA)ÊÇÒÔÂýÐÔ¶àÊàŦÑ×֢ΪÖ÷ÒªÌåÏÖµÄÂýÐÔÈ«ÉíÐÔ×ÔÉíÃâÒßÐÔ¼²²¡¡£Ö÷ÒªÀÛ¼°¹ÇÊàŦºÍÊàŦǻ£¬ÒÔÊàŦǻ»¬Ä¤Ñ×Ö¢¡¢ÉøÒº¡¢Ï¸°ûÔöÖ³¡¢ÈâÑ¿Ö×Ðγɡ¢Èí¹Ç¼°¹Ç×éÖ¯ÆÆËðΪÆäÖ÷ÒªµÄ²¡ÀíÑ§ÌØÕ÷¡£¶àÇÖռСÊàŦ£¬ÈçÊÖ¡¢×ã¼°ÍóÊàŦµÈ£¬³£Îª¶Ô³ÆÐÔ£¬³ÊÂýÐÔ¾ÓÉ¡£ÑªÇåÖпɲ鵽×ÔÉí¿¹ÌåѪÇåÀà·çʪÒò×Ó¡£·¢²¡ÄêËê¶àÔÚ20~40ËꡣŮÐÔ¶àÓÚÄÐÐÔ¡£
RAµÄ²¡ÒòºÍ·¢²¡»úÖÆÉÐδÍêÈ«ÇåÎú£¬Óë·¢²¡ÓйصÄÒòËØÓУº¢Ù×ÔÉíÃâÒß¹¦Ð§ÔÓÂÒ£º×ÔÉíÃâÒßϵͳµ÷Àí¹¦Ð§ÔÓÂÒËùÖµÄÑ×Ö¢·´Ó¦ÐÔ¼²²¡¡£¢ÚÒÅ´«£ºÓëÀà·çʪÊàŦÑ×·¢²¡Ïà¹ØµÄÒ׸лùÒò°üÀ¨HLADR¡¢PADI4ºÍPTPN22µÈ¡£±¾²¡»¼ÕßHLA-DRwu¿¹Ô¼ì³öÂÊÏÔ×ÅÉý¸ß£¬ÌáÐÑ·¢²¡ÓëÒÅ´«Óйء£¢ÛѬȾ£ºÓëÀà·çʪÊàŦÑ×·¢²¡Ïà¹ØµÄ²¡ÔÌå°üÀ¨EB²¡¶¾¡¢Ï¸Ð¡²¡¶¾B19¡¢Á÷¸Ð²¡¶¾¼°½áºË·ÖÖ¦¸Ë¾úµÈѬȾ¡£
RAµÄ¶¯ÎïÄ£×ÓÓÐÓÕ·¢ÐÔ¶¯ÎïÄ£×ÓºÍת»ùÒò¶¯ÎïÄ£×Ó2À࣬ÒÔÓÕ·¢ÐÔ¶¯ÎïÄ£×ÓʹÓÃ×îÆÕ±é¡£
ÖÁ½ñΪֹÔÚRAÑо¿ÉÏ£¬ÓÕ·¢ÐÔ¶¯ÎïÄ£×ÓÓ¦ÓÃ×î¹ã¡£Ëü²»µ«¿ÉÓÃÄö³ÝÀදÎïÖÆ×÷£¬Òà¿ÉÓÃÍá¢È®ºÍºï¡£ÓÕ·¢¼ÁµÄÖÖÀàÒàÐí¶à£¬ÆäÖÐAAÄ£×Ó¡¢CIAÄ£×ÓºÍOIAÄ£×Ó±¨µÀ½Ï¶à¡£µ«ÕâЩÓÕ·¢ÐÔ¶¯ÎïÄ£×ÓÔÚ²¡Àí¸Ä±äºÍÃâÒßϵͳµ÷ÀíÔÓÂÒÉÏÓëÈ˵ÄÁÙ´²ÌåÏÖÉÐÓÐÒ»¶¨µÄ²î±ð£¬ÈçûÓп¹ºË¿¹Ì壬ҲûÓÐRAµÄƤϽá½Ú¡¢½¬Ä¤Ñס¢Ñª¹ÜÑ×µÈÌåÏÖ£¬RA¶¯ÎïÄ£×ÓÖ»ÊÇÔÚÒ»¶¨Ìõ¼þÏ£¬×ÅÖØÓÚijһ¸ö»òij¼¸¸öÒòËØ¶ø½¨ÉèÆðÀ´µÄ£¬²»¿ÉÍêÈ«·´Ó¦RAµÄËùÓÐÌØµã¡£
²¿·ÖÔìÄ£ÒªÁì
ʹÓö¯Î´óÊó
¡¾ÔìÄ£»úÖÆ¡¿£º
×ô¼Á¿ÉÒýÆð¾Ö²¿ÁÜͶºÏµÄÑ×Ö¢·´Ó¦£¬ÓÐÀûÓڴ̼¤ÃâÒßϸ°ûµÄÔöÖ³×÷Óá£Óø£ÊÏÍêÈ«×ô¼Á(complete Freund's adjuvant,CFA)ÃâÒß¶¯Î¿É´Ì¼¤ÃâÒßϸ°ûµÄÔöÖ³£¬Ê¹¶¯Îï»úÌåÃâÒß¹¦Ð§Òì³£Ôö¸ß£¬±¬·¢Õë¶ÔÊàŦ»¬Ä¤µÄ×ÔÉíÃâÒß·´Ó¦£¬ÃâÒ߸´ºÏÎï³Á»ýÔÚÊàŦǻÄÚ£¬±¬·¢ÀàËÆÓÚÀà·çʪÐÔÊàŦÑ׵ĸı䡣
¡¾ÔìÄ£ÒªÁì¡¿£º
ÓÃҺ״ʯÀ¯ÓëÎÞË®Ñòë֬°´2:1»ò6:4±ÈÀý»ìÏý£¬¼ÓÈë80C°Ãð»î¿¨½éÃç(BCG)£¬µ÷ÖÆ³ÉŨ¶ÈΪ10g/LµÄBCGÈé¼Á£¬³ä·ÖÄëÄ¥£¬ÐγÉÓͰüË®Èé¼Á¡£½«³ä·ÖÈ黯»ìÔȵÄCFAÔÚ´óÊóºóÖ«×ãõŲ¿Æ¤ÏÂ×¢Éä·¨£¬Ò»²àÒ»´Î×¢Èë0.1ml¡£CFA×¢Éäºó£¬ÊÓ²ì´óÊóµÄ·´Ó¦¡¢ÊàŦÖ×ÕÍÇéÐΡ¢×éÖ¯²¡Àíѧ¸Ä±äÒÔ¼°ÁܰÍϸ°ûÑÇȺµÄ¸Ä±ä¡£¸ÃÄ£×Ó½ÐAA(adjuvant arthritis)´óÊóÄ£×Ó¡£
×¢ÖØ£º¢ÙÅäÖÆCFAʱ£¬Ó¦½«ÖÖÖÖÒòËØÔÚÑв§Öгä·ÖÑÐÄ¥£¬»òÓÃÈýͨ¹ÜÅþÁ¬Á½¸ö×¢ÉäÖØÊÓ¸´ÍÆ×¢£¬³ä·Ö»ìÔÈ£¬ÐγÉÓͰüË®Èé¼Á£¬ÒÔÑÓ»º×ô¼ÁÎüÊÕ£¬³¤Ê±¼ä´Ì¼¤ÃâÒßϵͳ¡£¢ÚÄêÓ×(<2ÈÕÁ䣩»òÄ곤(>9¸öÔÂÁ䣩µÄ´óÊó¾ù²»Ò×ÓÕµ¼×ô¼ÁÐÔÊàŦÑס£
¡¾Ä£×ÓÌØµã¡¿£º
AAÄ£×ÓÔ·¢²¡±äÖ÷ÒªÌåÏÖΪ¾Ö²¿µÄÑ×ÐÔ·´Ó¦£¬Ðø·¢²¡±äÒ»Ñùƽ³£ÓÚÖÂÑ׺ó10~20Ìì×óÓÒ·ºÆð£¬20Ìì×óÓÒµÖ´ïá¯Áë¡£Ñ×Ö¢ÒÔõ×ÊàÅ¦ÎªÖØ£¬¿ÉÇÖ¼°×ãµæ¡¢È«×ã¡£²¡Àí¸Ä±äΪ»¬Ä¤ÏÂ×éÖ¯Ñ×Ö¢£¬»¬Ä¤ÔöÉú£¬Ñª¹ÜôèÐγɣ¬Èí¹ÇÆÆËð£»4Öܺó£¬ÊàŦºìÖ×¼õÍË£¬¹ÇÖÊïÔÌ£¬Ð¹ÇÐγɣ¬ÊàŦ¼ä϶±äÕ£¬Ðγɲ»¿ÉÄæµÄÊàŦ¸Ä±ä¡£
¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º
AAÄ£×Ó¿ÉÓÃÓÚÀà·çʪÐÔÊàŦÑ׵ķ¢²¡»úÖÆ¡¢×ÔÉíÃâÒß²¡Àíµ÷ÀíµÄÑо¿ÒÔ¼°Àà·çʪÐÔÊàŦÑ×Ò©ÎïµÄҩЧѧÑо¿¡£
AA´óÊóÄ£×ÓÓÚÖÂÃôºó±¬·¢Ë«²àºóÖ«õ×ÊàŦÏÔ×ÅÖ×ÕÍ£¬ÖÂÃô²àõ×ÊàŦϵÑ×ÐÔÖ×ÕÍ£¬¶øÖÂÃô¶Ô²àÔòΪ¼Ì·¢ÐÔ×ÔÉíÃâÒßÐÔÖ×ÕÍ£¬ÌáÐÑAA´óÊóÄ£×ÓÓëRA»¼ÕßÔÚÊàŦÖ×ÕÍ·½Ãæ¾ßÓÐÏàËÆÐÔ¡£µ«AA´óÊóÄ£×ÓÌåÏÖÓÐÏÔ×ŵÄTϸ°û¹¦Ð§ÔÓÂÒÕ÷Ï󣬶øRA»¼Õß¶àͬʱÌåÏÖÓÐÌåÒººÍϸ°ûÃâÒß¹¦Ð§µÄÒì³££¬ÕâÊÇAA´óÊóÄ£×ÓÃâÒß¹¦Ð§ÔÓÂÒÓëRA»¼ÕߵIJî±ðÖ®´¦¡£
¸ÃÄ£×ÓµÄÒªÁì¼òÆÓÒ×ÐУ¬²¡ÀíÌåÏÖÒ²ÀàËÆÓÚRA£¬µ«È±·¦ÂýÐÔ²¡ÀíÀú³Ì£¬²¡±ä¾ßÓÐÒ»¶¨×ÔÏÞÐÔÔÚ²¡ÀíÐÄÀíѧµÈ·½ÃæÓÖÓÐÒ»¶¨µÄ²î±ð¡£µ¥¶ÀʹÓÃAA´óÊóÄ£×ÓÓÐÒ»¶¨¾ÖÏÞÐÔ¡£
²Î¿¼ÎÄÏ×£º
1.ÁõÇí£¬Íõ³¿Ñþ£¬·½½£ÇÇ£®Àà·çʪÐÔÊàŦÑ×¶¯ÎïÄ£×ÓµÄÑо¿Ï£Íû£®Ò½Ñ§×ÛÊö£¬2006, 12(5):313-316
2.Áֺ죬ºØÓÀ»³£¬ÀèÑ࣬µÈ£®¢òÐͽºÔÂѰ×Ó븥ÊÏÍêÈ«×ô¼Á´óÊóÊàŦÑ×Ä£×ӵĽ¨ÉèºÍ½ÏÁ¿£®ÖйúʵÑ鶯Îïѧ±¨£¬1999,7(1):1-6
3.Keffer J, Probert L, Cazlaris H, et al. Transgenic mic expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J, 1991, 10 (13):4025- 4031
4.McKenzie SE, Taylor SM, Malladi P, et al. The role of the human Fc receptor Fc gamma RIIA in the immune clearance of platelets: a transgenic mouse model. J Immunol, 1999, 162(7):4311-4318
5.Wooley PH. Animal models of rheumatoid arthritis. Curr Opin Rheumalol, 1991, 3 (3):407-420
6.Wollheim FA,Telhag H,Henricsson A,el al. Prevention of joint destruction in antigen induced arthritis. Clin lmmunol Immunopathol, 1994,70 (1):19-21
7.Hu Y, Cheng W, Cai W, el al. Advances in research on animal models of rheumatoid arthritis. Clin Rheumatol, 2013,32(2): 161-165